Studies of the development of congenital anomalies in embryos of riboflavin-deficient, galactoflavin fed rats. II. Role of the terminal elec-tron transport systems.
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000818:Animals; D000968:Antimycin A; D004032:Diet; D004579:Electron Transport; D005260:Female; D005333:Fetus / Q000378:metabolism; D005415:Flavins; D008431:Maternal-Fetal Exchange; D009206:Myocardium / Q000378:metabolism; D009243:NAD / Q000378:metabolism; D010920:Placenta / Q000378:metabolism; D011247:Pregnancy; D011248:Pregnancy Complications; D051381:Rats; D012256:Riboflavin / Q000037:antagonists & inhibitors*; D012257:Riboflavin Deficiency / Q000201:enzymology; D013385:Succinate Dehydrogenase / Q000378:metabolism
D005415:Flavins; D009243:NAD; D000968:Antimycin A; D013385:Succinate Dehydrogenase; D012256:Riboflavin